Cargando…

Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study

BACKGROUND: Treatment of congenital hemophilia A (HA) in Japan has greatly improved with the widespread adoption of prophylactic factor (F)VIII concentrates. However, it is unknown if this has translated into a real‐world reduction in disease and treatment burden. OBJECTIVES: To describe HA disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Azusa, Ioka, Akiko, Nakamura, Takao, Murakami, Yoichi, Makishima, Misako, Okada, Norihiro, Sakai, Michio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615292/ https://www.ncbi.nlm.nih.gov/pubmed/36320425 http://dx.doi.org/10.1002/rth2.12825

Ejemplares similares

ORIHIME study: real-world treatment patterns and clinical outcomes of 338 patients with acquired hemophilia A from a Japanese administrative database
por: Ogawa, Yoshiyuki, et al.
Publicado: (2022)

AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors
por: Matsushita, Tadashi, et al.
Publicado: (2022)

A Case of Acquired Hemophilia A and Congenital Hemophilia B
por: Fortier, Julia C, et al.
Publicado: (2022)

Measuring hemophilia caregiver burden: validation of the Hemophilia Caregiver Impact measure
por: Schwartz, Carolyn E., et al.
Publicado: (2017)

Trends in Lung Cancer Incidence by Histological Type in Osaka, Japan
por: Toyoda, Yasuhiro, et al.
Publicado: (2008)

Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia
por: Thorat, Teja, et al.
Publicado: (2018)

Real-World Experience of People with Hemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results from a Patient Experience Survey
por: Eichler, Hermann, et al.
Publicado: (2023)

Real-World Use of Albutrepenonacog Alfa, A Recombinant Coagulation Factor IX Albumin Fusion Protein, for Personalized Prophylaxis in Japanese Individuals With Hemophilia B: A Case Series
por: Nagao, Azusa, et al.
Publicado: (2023)

Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM)
por: Brod, Meryl, et al.
Publicado: (2023)

Serum albumin and mortality risk in a hyperendemic area of HCV infection in Japan
por: Nagao, Yumiko, et al.
Publicado: (2010)

Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management Survey
por: Hirai, Hiroyuki, et al.
Publicado: (2021)

Conditional survival for longer-term survivors from 2000–2004 using population-based cancer registry data in Osaka, Japan
por: Ito, Yuri, et al.
Publicado: (2013)

Mortality in congenital hemophilia A – a systematic literature review
por: Hay, Charles R. M., et al.
Publicado: (2020)

Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan
por: Ioka, Akiko, et al.
Publicado: (2016)

Capturing daily assessments and home treatment of congenital hemophilia with inhibitors: design, disposition, and implications of the Dosing Observational Study in Hemophilia (DOSE)
por: Young, Guy, et al.
Publicado: (2012)

Long‐term safety and efficacy of rIX‐FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B
por: Mancuso, Maria Elisa, et al.
Publicado: (2020)

Current Therapeutic Approach to Acute Myocardial Infarction in Patients with Congenital Hemophilia
por: Badescu, Minerva Codruta, et al.
Publicado: (2021)

Cardiovascular Risk Factors in Patients with Congenital Hemophilia: A Focus on Hypertension
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Assessment of Oral Health and Healthy Habits in Adult Patients with Congenital Hemophilia
por: Czajkowska, Sylwia, et al.
Publicado: (2022)

Atherosclerosis in Patients with Congenital Hemophilia: A Focus on Peripheral Artery Disease
por: Badescu, Minerva Codruta, et al.
Publicado: (2023)

Economic Burden of High-Responding Inhibitors in Patients with Hemophilia A in Taiwan
por: Tu, Tsu-Chiang, et al.
Publicado: (2013)

Economic burden of hemophilia B in the US: a systematic literature review
por: Li, Nanxin (Nick), et al.
Publicado: (2019)

Effectiveness and safety of an extended‐release tablet of sodium valproate for the prophylactic treatment of migraine: Postmarketing surveillance in Japan
por: Takeshima, Takao, et al.
Publicado: (2016)

Burden of caregivers of patients with neuronopathic and non-neuronopathic Gaucher disease in Japan: A survey-based study
por: Koto, Yuta, et al.
Publicado: (2023)

Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma
por: Kubo, Shoji, et al.
Publicado: (2022)

Identification of patients with congenital hemophilia in a large electronic health record database
por: Wang, Michael, et al.
Publicado: (2017)

ACTH therapy for West syndrome with severe hemophilia A
por: Kubota, Kazuo, et al.
Publicado: (2016)

HAEMOcare: The First International Epidemiological Study Measuring Burden of Hemophilia in Developing Countries
por: Gupta, Naresh, et al.
Publicado: (2019)

Surgical Treatment for Severe Scoliosis in Patients with Reduced Cardiorespiratory Function after Surgery for Congenital Heart Disease: A Report of Two Cases
por: Kinoshita, Hayato, et al.
Publicado: (2018)

The Impact of Japan's 2004 Postgraduate Training Program on Intra-Prefectural Distribution of Pediatricians in Japan
por: Sakai, Rie, et al.
Publicado: (2013)

Psychological burden predicts new-onset diabetes in men: A longitudinal observational study in the Fukushima Health Management Survey after the Great East Japan earthquake
por: Hirai, Hiroyuki, et al.
Publicado: (2022)

Porcine Model of Hemophilia A
por: Kashiwakura, Yuji, et al.
Publicado: (2012)

Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐term safety and efficacy in previously treated patients of all ages in the pathfinder8 study
por: Lentz, Steven R., et al.
Publicado: (2022)

Isolation of Bat Sarbecoviruses, Japan
por: Murakami, Shin, et al.
Publicado: (2022)

A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus
por: Nagao, Yumiko, et al.
Publicado: (2012)

The burden of insomnia in Japan
por: Mishima, Kazuo, et al.
Publicado: (2015)

Genetic medicine is accelerating in Japan
por: Hayashi, Saori, et al.
Publicado: (2022)

The impact of extended half-life versus conventional factor product on hemophilia caregiver burden
por: Schwartz, Carolyn E., et al.
Publicado: (2018)

Practice of Iranian Adolescents with Hemophilia in Prevention of Complications of Hemophilia
por: Valizadeh, Leila, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ro59bkm3j58povmhadn9hn7l60